The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,761.00
Bid: 1,757.50
Ask: 1,758.00
Change: 27.50 (1.59%)
Spread: 0.50 (0.028%)
Open: 1,736.00
High: 1,767.00
Low: 1,736.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Markets lifted by corporate earnings, China outlook

Thu, 24th Oct 2013 16:22

- FTSE 100 at levels not seen since May- China manufacturing PMI at seven-month high- Financials, miners and pharma stocks gaintechMARK 2,642.27 +0.68%FTSE 100 6,713.18 +0.58%FTSE 250 15,526.93 +0.21%UK markets set a fresh five-month high on Thursday as investors celebrated an improved outlook for China and digested a host of upbeat corporate earnings from across the globe.Strong gains amongst financials, miners and pharmaceutical stocks helped the FTSE 100 higher today, along with upbeat results from blue chips Shire and WPP. Strong earnings from US giants Ford and 3M and European peers Daimler and ABB also gave sentiment a boost on global equity markets today.London's benchmark index finished up 38.7 points at 6,713.18; it has not closed above this level since May 28th when it finished at 6,762.01.Global equity markets were on the up after figures from HSBC and Markit showed that activity in China's manufacturing sector rose to a seven-month high. The manufacturing purchasing managers' index (PMI) increased from 50.2 to 50.9, ahead of the consensus forecast of 50.4."Anything that's good for Chinese growth is viewed as positive for the global economy, which is why we're seeing European indices on the rise again [...] following the brief pull back yesterday," said Market Analyst Craig Erlam from Alpari.Markets largely shrugged off the Eurozone composite PMI, which measures activity in both the services and manufacturing sectors, as it unexpectedly fell from 52.2 to 51.5 in October. Nevertheless, the index remains in growth territory (above 50), which is likely to lift confidence as the region moves out of recession.Shire surges after Q3 beatDrugmaker Shire climbed after it increased its full-year earnings growth guidance from "double digit" to "mid-to-high teens" following a better-than-expected third quarter. Heavyweight pharmaceutical peers GlaxoSmithKline and AstraZeneca were also providing a lift on markets this afternoon.Aberdeen Asset Management was a high riser on the news it was in talks with Lloyds for the potential acquisition of Scottish Widows Investment Partnership. Lloyds, along with banking peers Standard Chartered, RBS and HSBC, were also in demand, as banks rebounded after the announcement of European Central Bank stress tests scared investors yesterday. The mining sector was putting in a decent performance today as stocks tracked metal prices higher and celebrated the improved outlook for China. Fresnillo and Vedanta were registering decent gains by the close.Advertising giant WPP advanced after reporting a 7.2% rise in revenue to £8.2bn in the first nine months on the back of acquisitions and new business wins.Ophir Energy jumped after confirming reports that it will sell a part interest in gas field blocks one, three and four in Tanzania.Heading the other way was High Street retailer Sports Direct which sank sharply after MASH Holdings, a company wholly owned by founder and Deputy Chairman Mike Ashley, sold 16m shares (a 2.7% stake) at 662.5p each, a 7.5% discount to Wednesday's closing price. The £106m sale reduced MASH's holding to 61.7%.Meanwhile, Debenhams tanked after saying it expects the retail marketplace to remain "highly competitive" as it reported full-year profits fell 2.7% to £154m.FTSE 100 - RisersShire Plc (SHP) 2,760.00p +9.31%Aberdeen Asset Management (ADN) 450.40p +5.83%Lloyds Banking Group (LLOY) 80.12p +2.84%Fresnillo (FRES) 1,022.00p +2.82%Petrofac Ltd. (PFC) 1,462.00p +2.67%Rolls-Royce Holdings (RR.) 1,174.00p +2.62%Vedanta Resources (VED) 1,088.00p +2.16%GlaxoSmithKline (GSK) 1,597.00p +1.69%British Land Co (BLND) 623.00p +1.63%GKN (GKN) 376.20p +1.57%FTSE 100 - FallersSports Direct International (SPD) 685.00p -3.79%William Hill (WMH) 388.60p -2.61%Marks & Spencer Group (MKS) 476.70p -1.79%Tullow Oil (TLW) 959.00p -1.44%Kingfisher (KGF) 367.90p -1.37%ITV (ITV) 192.60p -1.23%Centrica (CNA) 356.70p -1.03%Diageo (DGE) 2,012.50p -0.81%Severn Trent (SVT) 1,860.00p -0.80%Next (NXT) 5,210.00p -0.76%FTSE 250 - RisersOphir Energy (OPHR) 326.70p +9.12%Ferrexpo (FXPO) 196.10p +6.17%Kazakhmys (KAZ) 265.00p +5.41%Hochschild Mining (HOC) 168.50p +5.38%Inchcape (INCH) 644.50p +3.53%Essar Energy (ESSR) 123.50p +2.75%Man Group (EMG) 90.45p +2.67%Serco Group (SRP) 552.50p +2.31%TR Property Inv Trust (TRY) 231.00p +2.30%Rank Group (RNK) 153.80p +2.19%FTSE 250 - FallersDebenhams (DEB) 101.00p -8.76%Spirent Communications (SPT) 118.20p -4.29%Petra Diamonds Ltd.(DI) (PDL) 118.20p -3.35%Fisher (James) & Sons (FSJ) 1,082.00p -3.31%Cranswick (CWK) 1,064.00p -3.18%Euromoney Institutional Investor (ERM) 1,020.00p -3.13%Ocado Group (OCDO) 421.10p -2.97%Genus (GNS) 1,335.00p -2.84%Millennium & Copthorne Hotels (MLC) 599.50p -2.60%Alent (ALNT) 346.00p -2.54%BC
More News
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.